Recursion Pharmaceuticals, Inc.
Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $2.72
- 52-Week Range
- $2.50 – $5.24
- Market Cap
- $1.76B
- P/E (TTM)
- —
- EPS (TTM)
- -0.86
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.75
- PEG Ratio
- —
- Return on Equity
- -48.72%
- Return on Assets
- -23.89%
- Gross Margin
- 0.00%
- Operating Margin
- -734.17%
- Profit Margin
- 0.00%
- Current Ratio
- 5.01
- Debt/Equity
- 0.08
- Total Debt
- $74.70M
- Free Cash Flow
- $-203.12M
- Revenue Growth
- 258.50%
- Earnings Growth
- —
- Enterprise Value
- $1.29B
Market Snapshot
About
Recursion Pharmaceuticals, Inc. is a biotechnology company pioneering the use of artificial intelligence and machine learning in drug discovery. The company operates a massive biological and chemical dataset to identify new therapeutic candidates across multiple disease areas. Recursion combines experimental biology, automation, and computational power to industrialize drug discovery at scale.